These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3345291)

  • 21. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
    Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
    J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
    Takanashi M; Kadono Y; Tabata Y; Hibi S
    Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aplastic anemia before bone marrow transplantation and antilymphocyte globulin.
    Heimpel H
    Acta Haematol; 2000; 103(1):11-5. PubMed ID: 10705153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the immune system in myelodysplasia: implications for therapy.
    Sloand EM; Rezvani K
    Semin Hematol; 2008 Jan; 45(1):39-48. PubMed ID: 18179968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.
    Molldrem JJ; Leifer E; Bahceci E; Saunthararajah Y; Rivera M; Dunbar C; Liu J; Nakamura R; Young NS; Barrett AJ
    Ann Intern Med; 2002 Aug; 137(3):156-63. PubMed ID: 12160363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.
    Wang H; Liu H; Zhou JY; Zhang TT; Jin S; Zhang X; Chen SN; Li WY; Xu Y; Miao M; Wu DP
    Sci Rep; 2017 Mar; 7():43488. PubMed ID: 28262717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithymocyte globulin as conditioning regimen for bone marrow transplantation].
    Kobayashi R; Kumon K; Watanabe N; Iguchi A; Cho Y; Yoshida M; Arioka H; Naito H; Shikano T; Ishikawa Y
    Rinsho Ketsueki; 1997 Nov; 38(11):1183-8. PubMed ID: 9423335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome.
    Shima H; Isshiki K; Yamada Y; Yamazaki F; Takahashi T; Shimada H
    Bone Marrow Transplant; 2017 Apr; 52(4):653-655. PubMed ID: 28067878
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
    Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ
    Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living with severe aplastic anaemia for 22 years. A patient tells his story (supplemented with information from the Hematologic Clinic Basel, Switzerland).
    Kienle E; Nissen C
    Acta Haematol; 2000; 103(1):63-4. PubMed ID: 10799006
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Not Available].
    Majot M; Kadri N; Doucet J; Zulfiqar AA
    Soins Gerontol; 2017; 22(126):45-46. PubMed ID: 28687133
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aplastic anemia].
    Schrezenmeier H; Körper S; Höchsmann B
    Dtsch Med Wochenschr; 2014 Dec; 139(49):2503-6. PubMed ID: 25423456
    [No Abstract]   [Full Text] [Related]  

  • 34. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is survival enough for myelodysplastic syndromes?
    Santini V
    Leuk Res; 2009 Aug; 33(8):1017-8. PubMed ID: 19268362
    [No Abstract]   [Full Text] [Related]  

  • 36. The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
    Devillier R; Crocchiolo R; Castagna L; Fürst S; El Cheikh J; Faucher C; Prebet T; Etienne A; Chabannon C; Vey N; Esterni B; Blaise D
    Bone Marrow Transplant; 2012 May; 47(5):639-45. PubMed ID: 22307016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summaries for patients. Promising therapy for bone marrow failure from myelodysplastic syndromes.
    Ann Intern Med; 2002 Aug; 137(3):I-27. PubMed ID: 12160383
    [No Abstract]   [Full Text] [Related]  

  • 38. Mixed chimerism: good news or bad news?
    Parkman R
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):750-1. PubMed ID: 24732782
    [No Abstract]   [Full Text] [Related]  

  • 39. [Aplastic anemia: from children to adults].
    Kojima S; Hama A
    Rinsho Ketsueki; 2013 Aug; 54(8):721-5. PubMed ID: 24005431
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.
    Krishnamurthy P; Potter VT; Barber LD; Kulasekararaj AG; Lim ZY; Pearce RM; de Lavallade H; Kenyon M; Ireland RM; Marsh JC; Devereux S; Pagliuca A; Mufti GJ
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):562-8. PubMed ID: 23266740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.